
Childhood onset or late onset severe growth hormone deficiency Program in Pharmaceutical Benefits Scheme (PBS) 012-18112104

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines the PBS subsidised somatropin for patients with
childhood onset or late onset of severe growth hormone (GH) deficiency.

Severe growth hormone deficiency and listing dates

Severe growth hormone deficiency is a condition where the body is unable
to produce enough hormone which impairs the growth and development of
adults.

Listing dates: somatropin - 1 December 2018

See Written Authority Required Drugs for morer information

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
restriction and item codes, and the PBS and Services Australia websites.

Related links

Processing and National Demand Allocation (PaNDA)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA)

Process telephone authority approval application

Processing Written Authority Approval Request

Processing Written Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
